ePosters
Complex regional pain syndrome (CRPS) is marked by disproportionate limb pain, autonomic dysfunction, and neuroinflammation, often triggered by trauma or surgery. Affecting about 1.2% of adults with chronic pain, predominantly women, CRPS can cause severe disability and remains difficult to treat due to unclear pathophysiology and variable presentation.1 There is no established FDA approved therapy, thus clinicians trial individualized treatment plans. Sympathetic nerve blocks and Ketamine show promise for refractory CRPS.2,3
Carol Girgiss, MD
Resident
Cedars Sinai Medical Sinai
Oceanside, California, United States
Gene Lee, M.D.
Assistant Professor of Anesthesiology and Pain Medicine
Cedars-Sinai Medical Center, United States